標題: Titlebook: Engineering and Application of Pluripotent Stem Cells; Ulrich Martin,Robert Zweigerdt,Ina Gruh Book 2018 Springer International Publishing [打印本頁] 作者: 街道 時間: 2025-3-21 17:36
書目名稱Engineering and Application of Pluripotent Stem Cells影響因子(影響力)
書目名稱Engineering and Application of Pluripotent Stem Cells影響因子(影響力)學科排名
書目名稱Engineering and Application of Pluripotent Stem Cells網絡公開度
書目名稱Engineering and Application of Pluripotent Stem Cells網絡公開度學科排名
書目名稱Engineering and Application of Pluripotent Stem Cells被引頻次
書目名稱Engineering and Application of Pluripotent Stem Cells被引頻次學科排名
書目名稱Engineering and Application of Pluripotent Stem Cells年度引用
書目名稱Engineering and Application of Pluripotent Stem Cells年度引用學科排名
書目名稱Engineering and Application of Pluripotent Stem Cells讀者反饋
書目名稱Engineering and Application of Pluripotent Stem Cells讀者反饋學科排名
作者: 不可思議 時間: 2025-3-21 22:50 作者: 協議 時間: 2025-3-22 01:19
Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small pproaches will require efficient and highly reproducible processes for the mass production of well-characterized CM batches..On their way toward beating CMs, hPSCs initially undergo an epithelial-to-mesenchymal transition into a primitive-streak (PS)-like population that later gives rise to all endo作者: 脆弱么 時間: 2025-3-22 06:42 作者: 枯燥 時間: 2025-3-22 12:41 作者: Myosin 時間: 2025-3-22 12:57 作者: Myosin 時間: 2025-3-22 18:03
Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases,ative therapies and biomedical research. With the advancement of ZFNs, TALENs, and the CRISPR/Cas9 technology, straightforward and precise manipulation of the genome of human pluripotent stem cells (PSC) became possible, allowing relatively easy and fast generation of gene knockouts, integration of 作者: Intuitive 時間: 2025-3-22 22:37
Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells, selective growth advantage in culture. Additionally, there is evidence that reprogramming of human induced pluripotent stem cells (hiPSCs) introduces mutations. This poses a challenge to both the safety of clinical applications and the reliability of basic research using hPSCs carrying genomic vari作者: 令人悲傷 時間: 2025-3-23 02:45
Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery,in vitro systems are being developed to overcome some of these challenges. In particular, induced pluripotent stem cells (iPSCs) have provided the opportunity to generate human cell types that can be utilized for developing more disease-relevant cellular assay models. As the use of these complex mod作者: 和音 時間: 2025-3-23 05:51
https://doi.org/10.1007/978-3-319-73591-7pluripotency; small molecules; Transgene-Free iPSCs; Genome engineering; drug screening; tissue engineeri作者: 單調女 時間: 2025-3-23 13:01
Ulrich Martin,Robert Zweigerdt,Ina GruhPresents different bioengineering strategies applied to pluripotent stem cells.Explores the (re)programming to pluripotency.Reviews the use of pluripotent stem cells for tissue engineering and drug sc作者: 水汽 時間: 2025-3-23 16:34
Advances in Biochemical Engineering/Biotechnologyhttp://image.papertrans.cn/e/image/310995.jpg作者: coagulation 時間: 2025-3-23 21:07 作者: fructose 時間: 2025-3-23 22:47
Engineering and Application of Pluripotent Stem Cells978-3-319-73591-7Series ISSN 0724-6145 Series E-ISSN 1616-8542 作者: escalate 時間: 2025-3-24 06:23 作者: creditor 時間: 2025-3-24 09:19
An Expanded View of Infantile Esotropia,peutic products. The transition from laboratory-scale protocols to industrial-scale production is one of the first milestones to be achieved in order to use both human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) as the starting material for cellular products. The methods to 作者: Ferritin 時間: 2025-3-24 11:42
https://doi.org/10.1007/978-1-4612-2784-7pproaches will require efficient and highly reproducible processes for the mass production of well-characterized CM batches..On their way toward beating CMs, hPSCs initially undergo an epithelial-to-mesenchymal transition into a primitive-streak (PS)-like population that later gives rise to all endo作者: epinephrine 時間: 2025-3-24 17:26 作者: 阻止 時間: 2025-3-24 22:49 作者: BILE 時間: 2025-3-25 02:55
Observations and Final Remarks,ne for potential treatment of disease using unaffected cells. PSCs provide a unique opportunity to study and combat cardiovascular diseases, which continue to claim the lives of thousands each day. Here, we discuss the differentiation of PSCs into vascular cells, investigation of the functional capa作者: 哄騙 時間: 2025-3-25 04:37
Hideto Kawaratani,Hitoshi Yoshijiative therapies and biomedical research. With the advancement of ZFNs, TALENs, and the CRISPR/Cas9 technology, straightforward and precise manipulation of the genome of human pluripotent stem cells (PSC) became possible, allowing relatively easy and fast generation of gene knockouts, integration of 作者: falsehood 時間: 2025-3-25 08:14 作者: 討人喜歡 時間: 2025-3-25 12:27 作者: 人類 時間: 2025-3-25 16:36 作者: 合法 時間: 2025-3-25 21:11 作者: aggressor 時間: 2025-3-26 04:02
The Evolving Psyche of Law in Europeels is lengthy and fairly complicated, we lay out our experiences of the cultivation, differentiation, and quality control requirements to successfully utilize pluripotent stem cells in drug discovery.作者: Resign 時間: 2025-3-26 05:06
0724-6145 of pluripotent stem cells for tissue engineering and drug sc.?This book reviews the latest biotechnological advances with pluripotent stem cells, exploring their application in tissue engineering and medicinal chemistry. Chapters from expert contributors cover topics such as the production of transg作者: Mets552 時間: 2025-3-26 10:38 作者: 秘方藥 時間: 2025-3-26 15:37
Book 2018chemistry. Chapters from expert contributors cover topics such as the production of transgene-free induced pluripotent stem cells (iPSCs), expansion, controlled differentiation and programming of pluripotent stem cells, and their genetic instability. Particular attention is given to the application 作者: irradicable 時間: 2025-3-26 17:25 作者: MORT 時間: 2025-3-26 22:00
Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery,els is lengthy and fairly complicated, we lay out our experiences of the cultivation, differentiation, and quality control requirements to successfully utilize pluripotent stem cells in drug discovery.作者: Water-Brash 時間: 2025-3-27 02:23
Book 2018of the pluripotent stem cells for vascularision of engineered tissue and for drug screening..This book will appeal to researchers working in regenerative medicine and drug discovery, and to bioengineers and professionals interested in stem cell research..作者: 吞沒 時間: 2025-3-27 07:47
https://doi.org/10.1007/978-1-4614-2397-3rapeutics for the cure of a wide range of degenerative and other diseases. This review focuses on episomal and Sendai viral reprogramming modalities, which are the most popular methods for generating transgene-free human induced pluripotent stem cells (hiPSCs) from easily accessible cell sources.作者: 極少 時間: 2025-3-27 10:30
https://doi.org/10.1007/978-1-349-06112-9terials for generation of functional myocardial tissue in vitro. Scale-up to clinically relevant dimensions is mandatory, and tissue vascularization is most probably required both for preclinical in vivo testing in suitable large animal models and for clinical application.作者: Neutral-Spine 時間: 2025-3-27 15:46
https://doi.org/10.1007/978-94-6265-423-5that is important in minimising acquired genomic variation. Assessing genetic variation for its potential impact is becoming increasingly important as techniques to detect genome-wide variation improve.作者: 線 時間: 2025-3-27 17:55
Nonintegrating Human Somatic Cell Reprogramming Methods,rapeutics for the cure of a wide range of degenerative and other diseases. This review focuses on episomal and Sendai viral reprogramming modalities, which are the most popular methods for generating transgene-free human induced pluripotent stem cells (hiPSCs) from easily accessible cell sources.作者: 墻壁 時間: 2025-3-27 22:41
Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application,terials for generation of functional myocardial tissue in vitro. Scale-up to clinically relevant dimensions is mandatory, and tissue vascularization is most probably required both for preclinical in vivo testing in suitable large animal models and for clinical application.作者: LAST 時間: 2025-3-28 02:43 作者: Credence 時間: 2025-3-28 06:39 作者: gout109 時間: 2025-3-28 14:16
